January 17, 2018

Company will also exhibit at Booth 351 during the Meeting

ALBANY, N.Y., January 17, 2018 – AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, announced that three of the company’s analytical services experts will deliver a two-part presentation during MD&M West, Feb. 6-8 in Anaheim, Calif.

Brandon Zurawlow, associate director, container closure integrity testing; Frank Bieganousky, director, package and medical device testing; and John Iannone, director of extractables/leachables and impurities (E&L), will present “Ensuring Success when Bringing a Device to Market: Part 1 – Regulatory Testing and Part 2 – Product Development,” beginning at 10:15 a.m., Thursday, Feb. 8. Session attendees will gain insights into mitigating risk and how to achieve regulatory acceptance when designing and qualifying complex systems, such as combination products. Topics will include material selection, process optimization, biocompatibility, CCIT, E&L, risk assessment, and device functionality.

“Medical device development professionals are seeking guidance in managing the changing regulatory landscape,” said Iannone. “Understanding these requirements early-on has proven to drive a significantly more efficient product development process leading to a successful product release.”

MD&M West is one of the industry’s largest networking opportunities with more than 20,000 engineers and executives who are ready to forge business partnerships. AMRI will be featuring a variety of analytical services for medical devices and drug delivery, including E&L, biocompatibility, microbiology, mechanical and functional testing, CCIT, and packaging and distribution testing.

To arrange and schedule a meeting with AMRI (Booth No. 351) while attending MD&M, please make a request here.

About AMRI

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical and Solid State Services, API Manufacturing and Drug Product. For more information about AMRI, visit www.amriglobal.com.

 

 

 

Back to News